Find latest Myeloma videos · 600+ videos
J

The Relapsed and Refractory MM Patient: When Immune Approaches Are Ineffective

By Joseph Mikhael 8 Videos
148 views
November 10, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

15:58
Amgen Hematology

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy

Related Videos

International Congress on Cancer Metastasis

10th International Congress on Cancer Metastasis

Wed, Oct 29, 2025
21:06

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

1.4K views
28:15

ASH 2024 Review: Key Multiple Myeloma Abstracts

Cleveland Clinic Taussig Cancer Institute

N. Callander

489 views
19:28

ASH 2024 Summary: Multiple Myeloma Highlights and Clinical Implicati…

2024 ASH Annual Meeting Insights Hub

S. Al Hadidi

487 views
33:01

2024 Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

439 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.9K views
14:56

ASH 2024 Insights: POLARIX 5yr Update - Pola-R-CHP vs. R-CHOP in 1L …

2024 ASH Annual Meeting Insights Hub

G. Salles

235 views
11:49

ASH 2025 Review: Updates in Frontline & R/R DLBCL

University of Colorado Division of Hematology

M. Kamdar

190 views
15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

801 views
26:59

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

386 views
13:28

Debate: Using BCMA CAR-T in Early vs Late Line R/R MM Treatment

Louisville Hematology Highlights

K. Patel, S. Usmani

199 views
33:46

ASH 2024 Review: Key Updates in Non-Hodgkin Lymphoma

Cleveland Clinic Taussig Cancer Institute

P. Caimi

216 views
08:58

New

Transition of Care for Bispecific Antibodies in RRMM: Closing the Ga…

Cleveland Clinic Taussig Cancer Institute

S. Mazzoni

114 views
11:20

Real-World Characteristics and Outcomes in Patients With RRMM Receiv…

Adeel Khan

152 views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

522 views
11:17

CAR-T Strategies and Clinical Considerations for R/R MM

Moffitt Cancer Center

K. Patel

163 views
09:17

ASH 2024 Insights: Outcomes With Bispecific Antibodies Post-CAR T-Ce…

2024 ASH Annual Meeting Insights Hub

M. Melody

183 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

601 views
29:37

Making Sense in R/R Myeloma: Guideline-Based Current Approaches

Saurabh Chhabra

193 views
06:06

The Future of NDMM Treatment: Ongoing Trials and Key ASH 2024 Oral A…

University of Miami Sylvester Comprehensive Cancer Center

O. Landgren

102 views
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

616 views
AUTOPLAY